Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2013 by Cangene Corporation.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Cangene Corporation
ClinicalTrials.gov Identifier:
NCT00768287
First received: October 7, 2008
Last updated: January 29, 2014
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2014
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):